Researcher studying targeted cancer therapies. Prahallad and collaborators investigated feedback activation of EGFR during BRAF inhibition in colon cancer, connecting pathway adaptation with an inadequate drug response.[ref]
Articles by others on the same topic
There are currently no matching articles.